Weifeng Tang

16PUBLICATIONS
49CO-AUTHORS
Economic models and forecastingAutoimmunityPharmacogenomicsStatistical and quantitative geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 23, 2026
Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis.

|Feb 04, 2026
Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling.

Marija Kekic, Oleg Stepanov, Wenjuan Wang

|May 14, 2025
An Integrative Mechanistic Model of Type 1 IFN-Mediated Inflammation in Systemic Lupus Erythematosus.

Alina Volkova, Victor Sokolov, Florencia Tettamanti

|Dec 14, 2024
Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration.

Jin Dong, Pradeep Sharma, Rasha Emara

Pageof 3